Q3 2024
Released Nov 13, 2024, after the close
10-Q filed Nov 13, 2024, 44 days after period end · 0000950170-24-126343
Q3 2024 · 10-Q
Revenue—
Net Income-$2.85M-$2.85M N/M vs Q3 2023N/M vs Q2 2024
EPS Diluted-$0.06-$0.06 N/M vs Q3 2023N/M vs Q2 2024
Operating Income-$3,309,128N/M
Operating Cash Flowderived-$2,032,054N/M
Free Cash Flowderived-$2,032,060N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2024 | Q3 2023 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | — | $1.00M | — | — |
| Net Income | -$2.85M | -$723.11K | -$3.70M | -$2.38M |
| EPS Diluted | -$0.06 | -$0.01 | -$0.08 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR